Expanded health coverage sees an increase in enrollments; Antiabortion activists protest against CVS and Walgreens; $26,500 Alzheimer’s drug limits affordability
Nearly 16 Million People Have Selected Health Coverage in ACA Marketplaces
The Biden-Harris administration announced that nearly 16 million people have signed up for an Affordable Care Act (ACA) marketplace health plan since the start of the 2023 Marketplace Open Enrollment Period in November, according to the CMS. This record-breaking enrollment period saw an increase of 13% over last year and includes over 3 million new people to the marketplaces. This expansion has been a top priority for the Biden-Harris administration with the national uninsured rate reaching an all-time low earlier this year.
Antiabortion Activists Confront CVS and Walgreens
Antiabortion activists organized protests outside of CVS and Walgreens in at least 8 states plus Washington, DC, according to POLITICO. These protests are in response to the FDA’s decision to allow retail pharmacies such as CVS and Walgreens to sell abortion pills in states where its legal. These protests are part of a bigger plan to curb abortion access, by targeting big pharmacy chains, including a call-in campaign and a national boycott of chains.
New Alzheimer Drug Will Cost $26,500 A Year
The new drug, lecanemab (Leqembi), is intended to slow the progression of Alzheimer disease and is the second Alzheimer drug to be approved by the FDA in the last 2 years, according to NBC News. However, this drug comes at a high price of $26,500 a year, which would greatly limit the amount of people who could get the drug. Additionally, CMS coverage is restricted for new Alzheimer treatments to only include patients participating in clinical trials.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More